Literature DB >> 17578664

Epidemiology of basal-like breast cancer.

Robert C Millikan1, Beth Newman, Chiu-Kit Tse, Patricia G Moorman, Kathleen Conway, Lynn G Dressler, Lisa V Smith, Miriam H Labbok, Joseph Geradts, Jeannette T Bensen, Susan Jackson, Sarah Nyante, Chad Livasy, Lisa Carey, H Shelton Earp, Charles M Perou.   

Abstract

Risk factors for the newly identified "intrinsic" breast cancer subtypes (luminal A, luminal B, basal-like and human epidermal growth factor receptor 2-positive/estrogen receptor-negative) were determined in the Carolina Breast Cancer Study, a population-based, case-control study of African-American and white women. Immunohistochemical markers were used to subtype 1,424 cases of invasive and in situ breast cancer, and case subtypes were compared to 2,022 controls. Luminal A, the most common subtype, exhibited risk factors typically reported for breast cancer in previous studies, including inverse associations for increased parity and younger age at first full-term pregnancy. Basal-like cases exhibited several associations that were opposite to those observed for luminal A, including increased risk for parity and younger age at first term full-term pregnancy. Longer duration breastfeeding, increasing number of children breastfed, and increasing number of months breastfeeding per child were each associated with reduced risk of basal-like breast cancer, but not luminal A. Women with multiple live births who did not breastfeed and women who used medications to suppress lactation were at increased risk of basal-like, but not luminal A, breast cancer. Elevated waist-hip ratio was associated with increased risk of luminal A in postmenopausal women, and increased risk of basal-like breast cancer in pre- and postmenopausal women. The prevalence of basal-like breast cancer was highest among premenopausal African-American women, who also showed the highest prevalence of basal-like risk factors. Among younger African-American women, we estimate that up to 68% of basal-like breast cancer could be prevented by promoting breastfeeding and reducing abdominal adiposity.

Entities:  

Mesh:

Year:  2007        PMID: 17578664      PMCID: PMC2443103          DOI: 10.1007/s10549-007-9632-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  88 in total

1.  Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Authors:  Mi-Jung Kim; Jae Y Ro; Sei-Hyun Ahn; Hak Hee Kim; Sung-Bae Kim; Gyungyub Gong
Journal:  Hum Pathol       Date:  2006-07-18       Impact factor: 3.466

2.  General and abdominal obesity and survival among young women with breast cancer.

Authors:  Page E Abrahamson; Marilie D Gammon; Mary Jo Lund; Elaine W Flagg; Peggy L Porter; June Stevens; Christine A Swanson; Louise A Brinton; J William Eley; Ralph J Coates
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

Review 3.  Breast cancer in African-American women: differences in tumor biology from European-American women.

Authors:  Kandace Amend; David Hicks; Christine B Ambrosone
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

4.  Delays in breast cancer diagnosis and treatment by racial/ethnic group.

Authors:  Sherri Sheinfeld Gorin; Julia E Heck; Bin Cheng; Suzanne J Smith
Journal:  Arch Intern Med       Date:  2006-11-13

5.  Red meat intake and risk of breast cancer among premenopausal women.

Authors:  Eunyoung Cho; Wendy Y Chen; David J Hunter; Meir J Stampfer; Graham A Colditz; Susan E Hankinson; Walter C Willett
Journal:  Arch Intern Med       Date:  2006-11-13

6.  American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity.

Authors:  Lawrence H Kushi; Tim Byers; Colleen Doyle; Elisa V Bandera; Marji McCullough; Anne McTiernan; Ted Gansler; Kimberly S Andrews; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Sep-Oct       Impact factor: 508.702

7.  Identification of a basal-like subtype of breast ductal carcinoma in situ.

Authors:  Chad A Livasy; Charles M Perou; Gamze Karaca; David W Cowan; Diane Maia; Susan Jackson; Chiu-Kit Tse; Sarah Nyante; Robert C Millikan
Journal:  Hum Pathol       Date:  2007-02       Impact factor: 3.466

8.  Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.

Authors:  Stefano Calza; Per Hall; Gert Auer; Judith Bjöhle; Sigrid Klaar; Ulrike Kronenwett; Edison T Liu; Lance Miller; Alexander Ploner; Johanna Smeds; Jonas Bergh; Yudi Pawitan
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

9.  Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.

Authors:  Huiyan Ma; Leslie Bernstein; Malcolm C Pike; Giske Ursin
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

Review 10.  Causal models in epidemiology: past inheritance and genetic future.

Authors:  Paolo Vineis; David Kriebel
Journal:  Environ Health       Date:  2006-07-21       Impact factor: 5.984

View more
  411 in total

1.  Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type.

Authors:  Min Zhao; Patrick C Sachs; Xu Wang; Catherine I Dumur; Michael O Idowu; Valentina Robila; Michael P Francis; Joy Ware; Matthew Beckman; Aylin Rizki; Shawn E Holt; Lynne W Elmore
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

2.  Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.

Authors:  Qiao Zheng; Sarah M Dunlap; Jinling Zhu; Erinn Downs-Kelly; Jeremy Rich; Stephen D Hursting; Nathan A Berger; Ofer Reizes
Journal:  Endocr Relat Cancer       Date:  2011-07-11       Impact factor: 5.678

Review 3.  Practical implications of gene-expression-based assays for breast oncologists.

Authors:  Aleix Prat; Matthew J Ellis; Charles M Perou
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

4.  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.

Authors:  Amal Melhem-Bertrandt; Mariana Chavez-Macgregor; Xiudong Lei; Erika N Brown; Richard T Lee; Funda Meric-Bernstam; Anil K Sood; Suzanne D Conzen; Gabriel N Hortobagyi; Ana-Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

5.  Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.

Authors:  Mona L Gauthier; Hal K Berman; Caroline Miller; Krystyna Kozakeiwicz; Karen Chew; Dan Moore; Joseph Rabban; Yunn Yi Chen; Karla Kerlikowske; Thea D Tlsty
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

6.  Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

Authors:  Kristen S Purrington; Susan Slager; Diana Eccles; Drakoulis Yannoukakos; Peter A Fasching; Penelope Miron; Jane Carpenter; Jenny Chang-Claude; Nicholas G Martin; Grant W Montgomery; Vessela Kristensen; Hoda Anton-Culver; Paul Goodfellow; William J Tapper; Sajjad Rafiq; Susan M Gerty; Lorraine Durcan; Irene Konstantopoulou; Florentia Fostira; Athanassios Vratimos; Paraskevi Apostolou; Irene Konstanta; Vassiliki Kotoula; Sotiris Lakis; Meletios A Dimopoulos; Dimosthenis Skarlos; Dimitrios Pectasides; George Fountzilas; Matthias W Beckmann; Alexander Hein; Matthias Ruebner; Arif B Ekici; Arndt Hartmann; Ruediger Schulz-Wendtland; Stefan P Renner; Wolfgang Janni; Brigitte Rack; Christoph Scholz; Julia Neugebauer; Ulrich Andergassen; Michael P Lux; Lothar Haeberle; Christine Clarke; Nirmala Pathmanathan; Anja Rudolph; Dieter Flesch-Janys; Stefan Nickels; Janet E Olson; James N Ingle; Curtis Olswold; Seth Slettedahl; Jeanette E Eckel-Passow; S Keith Anderson; Daniel W Visscher; Victoria L Cafourek; Hugues Sicotte; Naresh Prodduturi; Elisabete Weiderpass; Leslie Bernstein; Argyrios Ziogas; Jennifer Ivanovich; Graham G Giles; Laura Baglietto; Melissa Southey; Veli-Matti Kosma; Hans-Peter Fischer; Malcom W R Reed; Simon S Cross; Sandra Deming-Halverson; Martha Shrubsole; Qiuyin Cai; Xiao-Ou Shu; Mary Daly; Joellen Weaver; Eric Ross; Jennifer Klemp; Priyanka Sharma; Diana Torres; Thomas Rüdiger; Heidrun Wölfing; Hans-Ulrich Ulmer; Asta Försti; Thaer Khoury; Shicha Kumar; Robert Pilarski; Charles L Shapiro; Dario Greco; Päivi Heikkilä; Kristiina Aittomäki; Carl Blomqvist; Astrid Irwanto; Jianjun Liu; Vernon Shane Pankratz; Xianshu Wang; Gianluca Severi; Arto Mannermaa; Douglas Easton; Per Hall; Hiltrud Brauch; Angela Cox; Wei Zheng; Andrew K Godwin; Ute Hamann; Christine Ambrosone; Amanda Ewart Toland; Heli Nevanlinna; Celine M Vachon; Fergus J Couch
Journal:  Carcinogenesis       Date:  2013-12-09       Impact factor: 4.944

Review 7.  Population and target considerations for triple-negative breast cancer clinical trials.

Authors:  Terry Hyslop; Yvonne Michael; Tiffany Avery; Hallgeir Rui
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

8.  Alcohol consumption and risk of breast cancer by molecular subtype: Prospective analysis of the nurses' health study after 26 years of follow-up.

Authors:  Kelly A Hirko; Wendy Y Chen; Walter C Willett; Bernard A Rosner; Susan E Hankinson; Andrew H Beck; Rulla M Tamimi; A Heather Eliassen
Journal:  Int J Cancer       Date:  2015-10-05       Impact factor: 7.396

9.  US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.

Authors:  Nadia Howlader; Sean F Altekruse; Christopher I Li; Vivien W Chen; Christina A Clarke; Lynn A G Ries; Kathleen A Cronin
Journal:  J Natl Cancer Inst       Date:  2014-04-28       Impact factor: 13.506

10.  Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.

Authors:  Carol Sweeney; Philip S Bernard; Rachel E Factor; Marilyn L Kwan; Laurel A Habel; Charles P Quesenberry; Kaylynn Shakespear; Erin K Weltzien; Inge J Stijleman; Carole A Davis; Mark T W Ebbert; Adrienne Castillo; Lawrence H Kushi; Bette J Caan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.